Parameter | Patients | GAL3ST1 | |||
---|---|---|---|---|---|
IHC (N = 232) | % | IHC negative | IHC positive | p value (chi-squarea or Fisher exact testb) | |
Age | |||||
 ≤ 50 years | 56 | 24.14 | 25 | 31 | 0.0904b |
 > 50 years | 176 | 75.86 | 102 | 74 | |
Tumour grade | |||||
 G1 | 67 | 28.88 | 30 | 38 | 0.0215 b |
 G2 | 96 | 41.38 | 53 | 42 | |
 G3 | 55 | 23.71 | 38 | 17 | |
 No data | 14 | 6.03 |  |  | |
Tumour size | |||||
 pT1 | 119 | 51.29 | 66 | 53 | 0.8706b |
 pT2 | 75 | 32.33 | 45 | 31 | |
 pT3 | 4 | 1.72 | 2 | 2 | |
 pT4 | 22 | 9.48 | 11 | 11 | |
 | 14 | 6.03 |  |  | |
Lymph nodes | |||||
 pN0 | 87 | 37.50 | 53 | 34 | 0.4386b |
 pN1–pN3 | 67 | 28.88 | 46 | 30 | |
 pNx |  | 0.00 |  |  | |
 No data | 12 | 5.17 |  |  | |
Stage | |||||
 I | 53 | 22.84 | 33 | 20 | 0.6406a |
 II | 60 | 25.86 | 35 | 25 | |
 III | 41 | 17.67 | 24 | 17 | |
 IV | 1 | 0.43 | 0 | 1 | |
 No data | 78 | 33.62 |  |  | |
Oestrogen receptor | |||||
 Negative | 52 | 22.41 | 36 | 16 | 0.0203 b |
 Positive | 167 | 71.98 | 85 | 82 | |
 No data | 13 | 5.60 |  |  | |
Progesterone receptor | |||||
 Negative | 69 | 29.74 | 40 | 28 | 0.4503b |
 Positive | 150 | 64.66 | 80 | 70 | |
 No data | 13 | 5.60 |  |  | |
HER2 | |||||
 Negative | 188 | 81.03 | 97 | 90 | 0.0894b |
 Positive | 34 | 14.66 | 23 | 11 | |
 No data | 10 | 4.31 |  |  | |
Molecular tumour types | |||||
 Triple negative | 18 | 7.6 | 11 | 7 | 0.5492b |
 Other types | 199 | 85.78 | 107 | 92 | |
 No data | 10 | 4.31 |  |  | |
Chemotherapy | |||||
 Negative | 13 | 5.60 | 8 | 5 | 0.7764b |
 Positive | 219 | 94.4 | 119 | 100 | |
Hormonal therapy | |||||
 Negative | 32 | 13.79 | 20 | 12 | 0.3398b |
 Positive | 198 | 85.34 | 103 | 95 | |
 No data | 2 | 0.8 |  |  |